Diagonal Therapeutics to Present Data at ASH 2024 Demonstrating the Economic and Clinical Burden of Hereditary ...
– Study finds annual healthcare costs per patient are significantly higher than previously described – HHT costs are higher than other expensive-to-treat rare diseases and exceedingly higher in people who are anemic and require hematological support, …